Multimodal therapy for malignant pleural mesothelioma including extrapleural pneumonectomy;Multimodale therapie des malignen pleuramesothelioms einschließlich der pleuropneumonektomie

Zentralblatt fur Chirurgie - Zeitschrift fur Allgemeine, Viszeral- und Gefasschirurgie

Volumn 133, Issue 3, 2008, Pages 231-237

  Sienel, W ^a   Kirschbaum, A ^a   Passlick, B ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Extrapleural pneumonectomy; Interdisciplinary cooperation; Malignant pleural; Mesothelioma; Multimodal therapy; Pemetrexed; Trimodal therapy

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LUNG RESECTION; LYMPH NODE METASTASIS; MALE; MESOTHELIOMA; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PLEURA; PLEURA TUMOR; PROGNOSIS;

AGED; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PLEURA; PLEURAL NEOPLASMS; PNEUMONECTOMY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 47249131296     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1076790     Document Type: Article

References (25)

1. Andreopoulou E, Ross PJ, O'Brien ME et al. The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma. Ann Oncol 2004; 15: 1406-1412
2. Bydder S, Phillips M, Joseph DJ et al. A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. Br J Cancer 2004; 91: 9-10
3. Dresler CM, Olak J, Herndon JE et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005; 127: 909-915
4. Gupta V, Mychalczak B, Krug L et al. Hemithoracic radiation therapy after pleurectomy / decortication for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2005; 63; 1045-1052
5. Manegold C. Malignant pleural mesothelioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007; 18 Suppl 2: ii34-ii35
6. Merritt N, Blewett CJ, Miller JD et al. Survival after conservative (palliative) management of pleural malignant mesothelioma. J Surg Oncol 2001; 78: 171-174
7. Opitz I, Kestenholz P, Lardinois D et al. Incidence and management of complications after neoadjuvant chemotherapy followed by extra-pleural pneumonectomy for malignant pleural mesothelioma. Eur J Cardiothorac Surg 2006; 29: 579-584
8. Pass HI, Kranda K, Temeck BK et al. Surgically debulked malignant pleural mesothelioma: results and prognostic factors. Ann Surg Oncol 1997; 4: 215-222
9. Pelucchi C, Malvezzi M, La Vecchia C et al. The Mesothelioma epidemic in Western Europe: an update. BrJ Cancer 2004; 90: 1022-1024
10. Peto J, Decarli A, La Vecchia C et al. The European mesothelioma epidemic. BrJ Cancer 1999; 79: 666-672
11. PillingJE, Stewart DJ, Martin-Ucar AE et al. The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma. Eur J Cardiothorac Surg 2004; 25: 497-501
12. Ruffie P, Feld R, Minkin S et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 1989; 7: 1157-1168
13. Rusch VW. A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group. Lung Cancer 1996; 14: 1-12
14. Rusch VW, Piantadosi S, Holmes EC. The role of extrapleural pneumonectomy in malignant pleural mesothelioma, A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg 1991; 102: 1-9
15. Rusch VW, Rosenzweig K, Venkatraman E et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001; 122: 788-795
16. Rusch VW, Venkatraman ES. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 1999; 68: 1799-1804
17. Soysal O, Karaoglanoglu N, Demiracan S et al. Pleurectomy/ decortication for palliation in malignant pleural mesothelioma: results of surgery. EurJ Cardiothorac Surg 1997; 11: 210-213
18. Stewart DJ, Martin-Ucar AE, Edwards JG et al. Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations. Eur J Cardiothorac Surg 2005; 27: 373-378
19. Sugarbaker DJ, Garcia JP, Richards WG et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg 1996; 224: 288-294
20. SugarbakerDJ,JaklitschMT, Bueno R et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 2004; 128: 138-146
21. Tannapfel A. Mesotheliome. Deutsches Mesotheliomregister http://www.bergmannsheil.de/57.0.html?&L=0.Zugriffsdatum 15.6.2007
22. van Ruth S, Baas P, Zoetmulder FA. Surgical treatment of malignant pleural mesothelioma: a review. Chest 2003; 123: 551-561
23. Vogelzang NJ, Rusthoven JJ, Symanowski J et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003; 21: 2636-2644
24. Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 1994; 120: 56-64
25. Weder W, Stahel R, Bernhard J et al. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007; 18(7): 1196-1202